Global mRNA Therapeutics Market Size By Application (Rare Genetic Diseases, Oncology), By Type (Prophylactic Vaccines, Therapeutic Vaccines), By End-Use (Hospitals And Clinics, Research Organizations), By Geographic Scope And Forecast

mRNA Therapeutics Market Size And Forecast

mRNA Therapeutics Market size was valued at USD 31.04 Billion in 2022 and is projected to reach USD 35.82 Billion by 2030, growing at a CAGR of 1.8% from 2023 to 2030.

Increased prevalence of long-lasting and communicable diseases driving market expansion. Additionally, an increase in the number of patients with infectious diseases, cancer, influenza, and respiratory illnesses is expected to fuel market growth. The Global mRNA Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global mRNA Therapeutics Market Definition

The basic principle of mRNA therapeutics involves the delivery of in vitro transcribed mRNA into a target cell, where the cellular machinery translates the mRNA into a functional protein. Whereas in therapeutic applications, an mRNA expressing an absent (or dysfunctional) protein in a patient delivers functional protein expression, in vaccine applications, an mRNA encoding a viral protein will elicit a protective immune response. As a result, the generation of vaccines, protein replacement therapy, and the treatment of genetic illnesses all make extensive use of mRNAs.

mRNA technology has a wide range of applications in the treatment or prevention of disease due to the essential function that mRNA plays in protein expression. Two mRNA-based coronavirus disease 2019 (COVID-19) vaccines have received Emergency Use Authorization, confirming the revolutionary method’s clinical viability. Lung and liver disorders are being treated with mRNA replacement therapy for hereditary diseases (inhaled and intravenous delivery). The inherent immunological adjuvant properties of mRNA can be used in immuno-oncologic strategies.

Global mRNA Therapeutics Market Overview

Increased Prevalence of Long-lasting and Communicable Diseases driving market expansion. Additionally, an increase in the number of patients with infectious diseases, cancer, influenza, and respiratory illnesses is expected to fuel market growth. For instance, an NCBI research said that in 2019, the WHO estimates that up to 500,000 people might die from influenza each year and that nearly one billion people will be unwell, which will likely lead to an increase in the number of hospitals and healthcare facilities.

Moreover, mRNA treatments, a rapidly increasing class of medications for numerous diseases, will revolutionize personalized medicine and alter current treatment protocols. It is anticipated that the mRNA-dependent product market will expand in the years to come. The rise in prevalence of rare diseases like propionic metabolic acidosis, sufficient concentration diabetic ketoacidosis, carbohydrate diseases, genetic defects, metabolic, and immunological disorders, as well as chronic diseases like heart disease, cancer, pulmonary, and CKD, is what is driving this market expansion. Because of its excellent potential for treating chronic diseases, RNA-based therapeutics have received a lot of interest in recent years.

Pharmaceutical companies are making investments in mRNA technology as another key factor stimulating growth since it allows them to combine various molecules into therapeutic drugs. Other factors, such as significant biotechnology-related research and development (R&D) initiatives and improvements in medical technology, are anticipated to drive the market. Additionally, RNA vaccines have a lot of advantages over DNA vaccines in terms of production, distribution, and safety. The need for mRNA vaccines and therapies has grown as a result of them showing promise in human clinical studies. Also, a significant rise in the number of mRNA-based vaccine treatments being tested in oncology clinical trials can be attributed to the success of the COVID-19 vaccines created by Moderna and Pfizer-BioNTech.

Global mRNA Therapeutics MarketSegmentation Analysis

The Global mRNA Therapeutics Market is Segmented on the basis of Application, Type, End-Use, and Geography.

mRNA Therapeutics Market, By Application

• Rare Genetic Diseases
• Oncology
• Respiratory Diseases
• Infectious Diseases
• Others

Based on Application, the market is segmented into Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases, and Others. In 2021, the segment for infectious diseases held the majority of the revenue. The market is expected to be driven by the rising use of mRNA-based vaccines, a large number of candidates beginning clinical trials for various infectious diseases, and the COVID-19 outbreak in late 2019. Over the period of the forecast period, the oncology segment is anticipated to grow at a lucrative rate. According to estimates from the World Health Organization (WHO), cancer accounted for approximately 10 million deaths in 2020, making it the leading cause of death globally.

mRNA Therapeutics Market, By Type

• Prophylactic Vaccines
• Therapeutic Vaccines
• Therapeutic Drugs

Based on Type, the market is segmented into Prophylactic Vaccines, Therapeutic Vaccines, and Therapeutic Drugs. The prophylactic vaccines segment dominated the market in 2021 with a significant market share. Prophylactic vaccinations are the focus of current R&D efforts, according to the article in Nature, with 77% of mRNA businesses having at least one preventive vaccine under development. Other vaccines for disorders including influenza and respiratory syncytial virus also contribute to the category growth, but COVID-19 products currently account for the vast bulk of preventive vaccine revenues.

mRNA Therapeutics Market, By End-Use

• Hospitals & Clinics
• Research Organizations
• Others

Based on End-Use, the market is segmented into Hospitals & Clinics, Research Organizations, and Others. In 2021, the hospitals and clinics segment had the largest revenue share, and it is anticipated that it will grow at the fastest rate over the next few years. The market for personalized pharmaceuticals is expanding as a result of the increased use of treatments and vaccines to treat a variety of chronic conditions. The increasing number of patients visiting hospitals and clinics is another factor driving this market segment.

mRNA Therapeutics Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Based on Geography, the Global mRNA Therapeutics Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market with a significant share in 2021 and would have the fastest growth throughout the forecast period. The market in North America will be driven by the availability of significant research funding, expanding federal programs for RNA-based therapeutics, and a rising number of clinical trials. For instance, Graham and others’ basic research was supported by the National Institutes of Health (NIH), the Defense Department, and federally financed academic laboratories in November 2020. This support was a key factor in the rapid discovery of vaccines against COVID-19. The government has given vaccine manufacturers an additional $10.5 billion since the pandemic began in order to speed up the delivery of their products.

Key Players

The “Global mRNA Therapeutics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Moderna, Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Translate Bio, Inc., GSK plc., Argos Therapeutics Inc., Sangamo Therapeutics, Inc., Pfizer Inc., AstraZeneca plc., and CRISPR Therapeutics AG. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global mRNA Therapeutics Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global mRNA Therapeutics Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.